Draper and Partners Awarded ARPA-H Funding to End Cold-Chain Dependence for Cell Therapies and Cancer Drugs
CAMBRIDGE, Mass., Oct. 7, 2026 /PRNewswire/ -- Draper received up to $7.3 million other transaction award (OTA) from the Advanced Research Projects Agency for Health (ARPA-H) for Phase 1 of the agency's BioStabilization Systems (BoSS) program, which aims to develop new methods to produce,...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.